狼疮患者认知功能障碍的患病率及测量工具的系统综述与Meta分析
该系统综述与Meta分析纳入78项使用特定神经心理学工具评估成人系统性红斑狼疮(SLE)患者认知功能障碍(CD)的研究。综合量表(CB)在2463例SLE患者中汇总患病率为38%(95%CI:33-43%),神经精神狼疮(NPSLE)中为39%(95%CI:24-55%)。SLE患者CD相对风险较类风湿关节炎(RA)和健康对照更高,RR分别为1.80和2.80。
要点
- 综合量表评估的SLE患者CD汇总患病率为38%(95%CI:33-43%)。
- NPSLE患者CD汇总患病率为39%(95%CI:24-55%)。
- SLE患者CD相对风险较RA和健康对照更高,RR分别为1.80和2.80。
核心结论
- 狼疮患者认知功能障碍患病率高。
- CD诊断延迟原因复杂,尽管照护者和患者表达对认知功能的担忧,但CD检测常带来行政和成本负担。
- 在识别CD最佳筛查和诊断指标方面存在未满足需求。
- 认知功能随时间评估及人口学特征与CD关联需进一步研究。
研究设计与样本
- 遵循PRISMA-P声明的系统综述与Meta分析。
- 检索Ovid Medline、Embase和PsycINFO数据库中关于成人SLE患者CD的文章。
- 纳入研究采用纽卡斯尔-渥太华量表(Newcastle-Ottawa Evaluation Scale)进行质量评价。
- 对所用工具的CD汇总患病率(PP)进行分析,并在信息充足时叙述性分析人口学特征与CD关联、SLE相较健康受试者和RA患者的CD风险及CD随时间病程。
主要发现
- 从8054篇文献中筛选670篇详细审阅,最终纳入78项研究。
- 综合量表(CB)在35项研究的2463例SLE患者中使用,CD汇总患病率为38%(95%CI:33-43%)。
- NPSLE中CD患病率更高,汇总患病率为39%(95%CI:24-55%)。
- 自动化神经心理学评估量表(ANAM)在7项研究的438例患者中使用,CD汇总患病率为26%(95%CI:12-42%)。
- SLE患者CD相对风险较RA和健康个体更高,RR分别为1.80和2.80。
关键数值与推荐
- 综合量表(CB)评估的CD汇总患病率为38%(95%CI:33-43%),基于35项研究的2463例SLE患者。
- NPSLE中CD汇总患病率为39%(95%CI:24-55%)。
- ANAM评估的CD汇总患病率为26%(95%CI:12-42%),基于7项研究的438例患者。
- SLE患者CD相对风险较RA的RR为1.80,较健康个体的RR为2.80。
- 其他较少使用的工具包括改良简易精神状态检查(MMSE)、蒙特利尔认知评估(MoCA)、受控口头词语联想测验(COWAT)、霍普金斯词语学习测验修订版(HVLT-R)及主观工具等。
临床怎么用
- 原文未据此给出推荐。
局限性
- 各研究间人口学特征与CD关联的信息异质性很大。
- 认知功能随时间评估及人口学特征与CD关联需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To systematically review the literature on the prevalence of Cognitive Dysfunction (CD) in SLE patients in studies that used a specified neuropsychological instrument. METHODS: This review was prepared with a protocol following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis-Protocols statement. Literature search in Ovid Medline, Embase, and Psyc INFO for articles on CD in adult SLE patients was conducted. Included studies were critically appraised (Newcastle-Ottawa Evaluation Scale) and the Pooled Prevalence (PP) of CD was studied for all instruments. The association between demographics and CD, the risk of CD in SLE compared to healthy subjects and patients with RA, and the course of CD over time were studied narratively whenever sufficient information was available. RESULT: Of 8054 references, 670 were selected for detailed review and 78 were included in the final analysis. Comprehensive Battery (CB) was utilized in 35 studies in 2463 SLE patients and PP was 38% (95%; CI: 33-43%). The CD prevalence was higher in NPSLE [PP 39% (95% CI: 24-55%]. Automated Neuropsychological Assessment Metric (ANAM) was utilized in 7 studies in 438 patients (PP of CD 26% (95% CI: 12-42%). Other less frequently utilized tools were the Modified Mini-Mental State Exam (MMSE), Montreal Cognitive Assessment (MoCA), Controlled Oral Word Association Test (COWAT) and The Hopkins Verbal Learning Test-Revised (HVLT-R) and subjective tools and others. The relative risk for CD in SLE was greater when compared to RA and to healthy individuals; RR being 1.80 and 2.80, respectively. Information on demographics and its association with CD was very heterogeneous among studies. CONCLUSION: Patients with lupus have a high prevalence of CD. The delay in diagnosis of CD is complex; although caregivers and patients express concerns about cognitive function, testing for CD often imposes administrative and cost burdens. There is an unmet need to identify the best screening, diagnostic metrics of CD. The assessment of cognitive function over time, and the association of demographics with CD, will require further research.
引用
- Rayes HA, Tani C, Kwan A, et al. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum. 2018. PMID: 29571540. doi:10.1016/j.semarthrit.2018.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。